WallStreetZen

NASDAQ: SGRY
Surgery Partners Inc Stock Forecast, Predictions & Price Target

Analyst price target for SGRY

Based on 4 analysts offering 12 month price targets for Surgery Partners Inc.
Min Forecast
$50.00+18.04%
Avg Forecast
$56.50+33.38%
Max Forecast
$73.00+72.33%

Should I buy or sell SGRY stock?

Based on 4 analysts offering ratings for Surgery Partners Inc.
Strong Buy
Strong Buy
2 analysts 50%
Buy
1 analysts 25%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

SGRY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Barclays
Bottom 13%
13
Strong BuyInitiates Coverage On$73.00+72.33%2021-11-30
Stifel Nicolaus
Bottom 32%
32
Strong BuyUpgrades$51.00+20.40%2021-11-29
SVB Leerink
Top 36%
65
BuyMaintains$52.00+22.76%2021-11-03
Anonymous
JP Morgan
HoldInitiates Coverage On$50.00+18.04%2021-11-01
Cowen & Co.
Bottom 4%
4
HoldInitiates Coverage On$50.00+18.04%2021-09-10

1 of 1

Forecast return on equity

Is SGRY forecast to generate an efficient return?
Company
N/A
Industry
4.52%
Market
37.5%

Forecast return on assets

Is SGRY forecast to generate an efficient return on assets?
Company
N/A
Industry
0.08%

SGRY earnings per share forecast

What is SGRY's earnings per share in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$0.23-82.84%
Avg 2 year Forecast
$0.34-125.37%

SGRY revenue forecast

What is SGRY's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$2.2B+3.49%
Avg 2 year Forecast
$2.5B+13.95%
Avg 3 year Forecast
$2.7B+25.85%
SGRY's revenue is forecast to grow at a rate of 7.88% per year, which is not exceptional
Forecast

SGRY revenue growth forecast

How is SGRY forecast to perform vs Medical Care Facilities companies and vs the US market?
Company
7.88%
Industry
6.87%
Market
10.08%
SGRY's revenues are forecast to grow faster (7.88% per year) than the US Medical Care Facilities industry average (6.87%)
Forecast
SGRY's revenues are forecast to grow slower (7.88% per year) than the US market average (10.08%)
Forecast

Surgery Partners Stock Forecast FAQ

Is Surgery Partners Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: SGRY) stock is to Strong Buy SGRY stock.

Out of 4 analysts, 2 (50%) are recommending SGRY as a Strong Buy, 1 (25%) are recommending SGRY as a Buy, 1 (25%) are recommending SGRY as a Hold, 0 (0%) are recommending SGRY as a Sell, and 0 (0%) are recommending SGRY as a Strong Sell.

What is SGRY's earnings growth forecast for 2021-2022?

(NASDAQ: SGRY) Surgery Partners's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 1.34%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.37%.

Surgery Partners's earnings in 2021 is -$85,900,000.On average, 2 Wall Street analysts forecast SGRY's earnings for 2021 to be $-18,960,446, with the lowest SGRY earnings forecast at $-22,257,914, and the highest SGRY earnings forecast at $-15,662,977.

In 2022, SGRY is forecast to generate $28,028,485 in earnings, with the lowest earnings forecast at $13,189,875 and the highest earnings forecast at $42,042,727.

What is SGRY's revenue growth forecast for 2021-2023?

(NASDAQ: SGRY) Surgery Partners's forecast annual revenue growth rate of 7.88% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.87%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Surgery Partners's revenue in 2021 is $2,163,200,000.On average, 5 Wall Street analysts forecast SGRY's revenue for 2021 to be $184,553,063,545, with the lowest SGRY revenue forecast at $183,075,467,776, and the highest SGRY revenue forecast at $185,534,555,134. On average, 5 Wall Street analysts forecast SGRY's revenue for 2022 to be $203,207,668,914, with the lowest SGRY revenue forecast at $197,437,593,134, and the highest SGRY revenue forecast at $212,502,903,714.

In 2023, SGRY is forecast to generate $224,431,826,845 in revenue, with the lowest revenue forecast at $217,994,013,634 and the highest revenue forecast at $229,303,507,250.

What is SGRY's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: SGRY) forecast ROA is N/A, which is lower than the forecast US Medical Care Facilities industry average of 0.08%.

What is SGRY's Price Target?

According to 4 Wall Street analysts that have issued a 1 year SGRY price target, the average SGRY price target is $56.50, with the highest SGRY stock price forecast at $73.00 and the lowest SGRY stock price forecast at $50.00.

On average, Wall Street analysts predict that Surgery Partners's share price could stay at $56.50 by Nov 30, 2022. The average Surgery Partners stock price prediction forecasts a potential downside of N/A from the current SGRY share price of $42.36.

What is SGRY's Earnings Per Share (EPS) forecast for 2021-2022?

(NASDAQ: SGRY) Surgery Partners's current Earnings Per Share (EPS) is -$1.34. On average, analysts forecast that SGRY's EPS will be $-0.23 for 2021, with the lowest EPS forecast at $-0.27, and the highest EPS forecast at $-0.19. In 2022, SGRY's EPS is forecast to hit $0.34 (min: $0.16, max: $0.51).

What is SGRY's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: SGRY) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.